HealthDay News — The combination drug Epclusa has been approved by the US Food and Drug Administration to treat the 6 major strains of chronic hepatitis C virus. Epclusa combines sofosbuvir, ...
FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced new research to be presented at The Liver Meeting ® 2024, hosted by the American Association for the Study of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results